Your session is about to expire
← Back to Search
Device
Treadmetrix Validation for Balance Assessment
N/A
Recruiting
Led By Kenton Kaufman, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Healthy adults with no medical conditions or previous injuries, trauma, or surgeries that reduce balance, mobility, or strength
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of participant test session (approximately 2 hours)
Awards & highlights
Study Summary
This trial will test how well a machine can create controlled falls, to help researchers understand how to better treat people with balance disorders.
Who is the study for?
This trial is for healthy adults who can follow instructions and have no medical conditions, injuries, or surgeries affecting balance, mobility, or strength. There are no restrictions based on gender, race, or ethnicity. People with chronic pain in major joints or the back or those using assistive devices like walkers cannot participate.Check my eligibility
What is being tested?
The study is testing 'Treadmetrix', a microprocessor-controlled treadmill designed to deliver controlled postural disturbances. The goal is to validate how accurately this equipment can simulate these disturbances for research purposes.See study design
What are the potential side effects?
Since this trial involves physical activity on a treadmill that simulates disturbances in posture, potential side effects may include muscle soreness, fatigue, and risk of falls during the test.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a healthy adult with no conditions or past injuries affecting my balance, mobility, or strength.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ duration of participant test session (approximately 2 hours)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of participant test session (approximately 2 hours)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Estimate the limits of agreement between observed and commanded treadmill belt disturbance parameters: average initial acceleration.
Estimate the limits of agreement between observed and commanded treadmill belt disturbance parameters: belt displacement.
Estimate the limits of agreement between observed and commanded treadmill belt disturbance parameters: peak velocity.
Secondary outcome measures
Kinetic loading exerted on treadmill during perturbations: treadmill force.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Balance assessment on specialized treadmillExperimental Treatment1 Intervention
Subjects will undergo a balance assessment on a microprocessor-controlled treadmill
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,764 Total Patients Enrolled
Kenton Kaufman, PhDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
80 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am willing to participate in the study.I can understand and follow basic instructions.I am a healthy adult with no conditions or past injuries affecting my balance, mobility, or strength.I am a healthy adult with no conditions or past injuries affecting my balance, mobility, or strength.My gender, race, or ethnicity does not affect my eligibility.I have ongoing pain in my joints or back.I use a walker or cane for mobility.I am willing to participate in the study.
Research Study Groups:
This trial has the following groups:- Group 1: Balance assessment on specialized treadmill
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger